Pia Kasperkovitz

Pia Kasperkovitz has over 15 years of work experience in the field of toxicology and preclinical development. Currently, they are working as the Senior Director of Toxicology at Bright Peak Therapeutics since January 2023. Prior to this, Pia worked at Roche as a Toxicology Project Leader from July 2019 to December 2022. Pia also served as a Project Team Toxicologist at Takeda Oncology from November 2017 to April 2019 and as an Associate Director of Preclinical Development at bluebird bio from June 2016 to November 2017. In addition, Pia worked at Alnylam Pharmaceuticals as a Senior Scientist of Preclinical Development from July 2011 to June 2016. Before their industry experience, they held research fellow and postdoctoral associate positions at Harvard Medical School / Massachusetts General Hospital, Whitehead Institute, and UMass Medical School.

Pia Kasperkovitz obtained their Ph.D. in Immunology from the Vrije Universiteit Amsterdam (VU Amsterdam) between 2001 and 2006. Prior to that, they completed their M.Sc. degree in Molecular Cell Biology and Immunology at Utrecht University from 1996 to 2001. Pia's earlier education is not specified in the provided information.